Disclosures Dr Shaker is a member of the Joint Task Force on Practice Parameters; serves on the editorial board of The Journal of Allergy and Clinical Immunology In Practice; is an associate editor of Annals of Allergy, Asthma & Immunology; and serves on the Board of Directors of the American Academy of Allergy, Asthma, & Immunology (views expressed are his own). Dr Wallace has served on the advisory/consulting boards of Genentech, ARS, AbbVie, Bryn, and Grisfol. Dr Lang has carried out clinical research with, served as a consultant for, and received honoraria from AstraZeneca, Blueprint Medicines, Celldex Therapeutics, Genentech, Novartis, and Sanofi/Regeneron.